Glycomimetics Stock Alpha and Beta Analysis
| GLYC Stock | USD 0.23 0.01 2.87% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as GlycoMimetics. It also helps investors analyze the systematic and unsystematic risks associated with investing in GlycoMimetics over a specified time horizon. Remember, high GlycoMimetics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to GlycoMimetics' market risk premium analysis include:
Beta (2.41) | Alpha 2.2 | Risk 24.46 | Sharpe Ratio 0.0862 | Expected Return 2.11 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
GlycoMimetics |
GlycoMimetics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. GlycoMimetics market risk premium is the additional return an investor will receive from holding GlycoMimetics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GlycoMimetics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate GlycoMimetics' performance over market.| α | 2.20 | β | -2.41 |
GlycoMimetics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of GlycoMimetics' Buy-and-hold return. Our buy-and-hold chart shows how GlycoMimetics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.GlycoMimetics Market Price Analysis
Market price analysis indicators help investors to evaluate how GlycoMimetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlycoMimetics shares will generate the highest return on investment. By understating and applying GlycoMimetics stock market price indicators, traders can identify GlycoMimetics position entry and exit signals to maximize returns.
GlycoMimetics Return and Market Media
The median price of GlycoMimetics for the period between Wed, Sep 18, 2024 and Tue, Dec 17, 2024 is 0.24 with a coefficient of variation of 41.56. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 0.26, and mean deviation of 0.1. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Capital One Initiates Coverage of GlycoMimetics with Overweight Recommendation - MSN | 09/24/2024 |
2 | SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy Progress of Other... | 10/02/2024 |
3 | Acquisition by Chinmaya Rath of 250000 shares of GlycoMimetics at 3.11 subject to Rule 16b-3 | 10/11/2024 |
4 | GlycoMimetics Announces National Cancer Institute Phase 23 Study of Uproleselan Did Not Meet Primary Endpoint | 10/29/2024 |
5 | GlycoMimetics Sees Unusually Large Options Volume | 10/31/2024 |
6 | GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting | 11/06/2024 |
7 | GlycoMimetics Earns Sell Rating from Analysts at StockNews.com | 12/11/2024 |
About GlycoMimetics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including GlycoMimetics or other stocks. Alpha measures the amount that position in GlycoMimetics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2023 | 2024 (projected) | Days Sales Outstanding | 0.42 | 6.4K | 6.7K | PTB Ratio | 0.91 | 3.89 | 1.98 |
GlycoMimetics Upcoming Company Events
As portrayed in its financial statements, the presentation of GlycoMimetics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GlycoMimetics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of GlycoMimetics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of GlycoMimetics. Please utilize our Beneish M Score to check the likelihood of GlycoMimetics' management manipulating its earnings.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with GlycoMimetics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out GlycoMimetics Backtesting, GlycoMimetics Valuation, GlycoMimetics Correlation, GlycoMimetics Hype Analysis, GlycoMimetics Volatility, GlycoMimetics History and analyze GlycoMimetics Performance. For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
GlycoMimetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.